Probiotics Clostridium butyricum and Bacillus subtilis ameliorate intestinal tumorigenesis.
Future Microbiol
; 10(9): 1433-45, 2015.
Article
em En
| MEDLINE
| ID: mdl-26346930
AIMS: To investigate the antitumor effects of probiotics Clostridium butyricum and Bacillus subtilis on colorectal cancer (CRC) progression. MATERIALS & METHODS: The effects of C. butyricum and B. subtilis on CRC cells were studied. Male C57BL/6 mice with 1,2-dimethylhydrazine dihydrochloride (DMH)-induced CRC were intervened by these two probiotics and the antitumor effects were examined by comparing the tumor incidence and detecting the inflammatory and immune-related markers. RESULTS & CONCLUSIONS: C. butyricum and B. subtilis inhibited the proliferation of CRC cells, caused cell cycle arrest and promoted apoptosis. In vivo, these two probiotics inhibited the development of DMH-induced CRC. The molecular mechanism involved reduced inflammation and improved immune homeostasis. This work establishes a basis for the protective role of probiotics B. subtilis and C. butyricum in intestinal tumorigenesis.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Bacillus subtilis
/
Neoplasias Colorretais
/
Probióticos
/
Clostridium butyricum
/
Carcinogênese
Limite:
Animals
Idioma:
En
Ano de publicação:
2015
Tipo de documento:
Article